Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RBMS3 |
| Upstream (Parents) |
|---|
| (<<) C5orf13 → RBMS3 |
| (<<) PRAF2 → RBMS3 |
| (<<) UNC5B → RBMS3 |
| (<<) ZEB1 → RBMS3 |
| (<<) OLFML1 → RBMS3 |
| (<<) SETBP1 → RBMS3 |
| Downstream (Children) |
|---|
| RBMS3 → RAI2 (>>) |
| RBMS3 → YPEL1 (>>) |
| RBMS3 → UNC5B (>>) |
| RBMS3 → SERPINB4 (>>) |
| RBMS3 → RAB9BP1 (>>) |
| RBMS3 → MYH4 (>>) |
| RBMS3 → THRA (>>) |
| RBMS3 → NME5 (>>) |
| RBMS3 → FAM75A5///FAM75A3///FAM75A1///FAM75A4///FAM75A2///FAM75A6///FAM75A7 (>>) |
| RBMS3 → ZNF667 (>>) |
| RBMS3 → PCDHGB6 (>>) |
| RBMS3 → RAD54L2 (>>) |
| RBMS3 → ELL2 (>>) |
| RBMS3 → P2RY6 (>>) |
| RBMS3 → FBXL8 (>>) |
| RBMS3 → CNTNAP3B (>>) |
| RBMS3 → LLPH (>>) |
| RBMS3 → MPP2 (>>) |
| RBMS3 → FZD1 (>>) |
